6756 — VIA Labs Income Statement
0.000.00%
- TWD6.50bn
- TWD5.16bn
- TWD1.70bn
Annual income statement for VIA Labs, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,970 | 3,367 | 2,955 | 2,035 | 1,700 |
Cost of Revenue | |||||
Gross Profit | 961 | 1,795 | 1,546 | 931 | 851 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Total Operating Expenses | 1,584 | 2,337 | 2,245 | 1,879 | 1,686 |
Operating Profit | 386 | 1,030 | 710 | 156 | 14.6 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 358 | 1,041 | 848 | 214 | 180 |
Provision for Income Taxes | |||||
Net Income After Taxes | 318 | 880 | 724 | 181 | 152 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 318 | 880 | 724 | 181 | 157 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 318 | 880 | 724 | 181 | 157 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 5.04 | 12.5 | 10.2 | 2.57 | 2.23 |
Dividends per Share |